72 related articles for article (PubMed ID: 16438649)
1. The Effect of a Single Nucleotide Substitution in the Splicing Silencer in the tat/rev Intron on HIV Type 1 Envelope Expression.
Paca-Uccaralertkun S; Damgaard CK; Auewarakul P; Thitithanyanont A; Suphaphiphat P; Essex M; Kjems J; Lee TH
AIDS Res Hum Retroviruses; 2006 Jan; 22(1):76-82. PubMed ID: 16438649
[TBL] [Abstract][Full Text] [Related]
2. hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure.
Damgaard CK; Tange TO; Kjems J
RNA; 2002 Nov; 8(11):1401-15. PubMed ID: 12458794
[TBL] [Abstract][Full Text] [Related]
3. The strength of the HIV-1 3' splice sites affects Rev function.
Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
[TBL] [Abstract][Full Text] [Related]
4. A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding.
Marchand V; Méreau A; Jacquenet S; Thomas D; Mougin A; Gattoni R; Stévenin J; Branlant C
J Mol Biol; 2002 Nov; 323(4):629-52. PubMed ID: 12419255
[TBL] [Abstract][Full Text] [Related]
5. The tat/rev intron of human immunodeficiency virus type 1 is inefficiently spliced because of suboptimal signals in the 3' splice site.
Staffa A; Cochrane A
J Virol; 1994 May; 68(5):3071-9. PubMed ID: 7512159
[TBL] [Abstract][Full Text] [Related]
6. Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains.
Bilodeau PS; Domsic JK; Stoltzfus CM
J Virol; 1999 Dec; 73(12):9764-72. PubMed ID: 10559286
[TBL] [Abstract][Full Text] [Related]
7. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.
Amendt BA; Si ZH; Stoltzfus CM
Mol Cell Biol; 1995 Aug; 15(8):4606-15. PubMed ID: 7623852
[TBL] [Abstract][Full Text] [Related]
8. Regulation of HIV-1 envelope protein synthesis by Tat and Rev in 293 cells.
Natarajan V; Radjendirane V; Salzman NP
Virology; 1993 Sep; 196(1):122-9. PubMed ID: 8356789
[TBL] [Abstract][Full Text] [Related]
9. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
Najera I; Krieg M; Karn J
J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
[TBL] [Abstract][Full Text] [Related]
10. Rev inhibition strongly affects intracellular distribution of human immunodeficiency virus type 1 RNAs.
Cmarko D; Bøe SO; Scassellati C; Szilvay AM; Davanger S; Fu XD; Haukenes G; Kalland KH; Fakan S
J Virol; 2002 Oct; 76(20):10473-84. PubMed ID: 12239324
[TBL] [Abstract][Full Text] [Related]
11. In silico mutagenesis of RNA splicing in HIV-1.
Kim H; Yin J
Biotechnol Bioeng; 2005 Sep; 91(7):877-93. PubMed ID: 15937951
[TBL] [Abstract][Full Text] [Related]
12. hnRNP E1 and E2 have distinct roles in modulating HIV-1 gene expression.
Woolaway K; Asai K; Emili A; Cochrane A
Retrovirology; 2007 Apr; 4():28. PubMed ID: 17451601
[TBL] [Abstract][Full Text] [Related]
13. High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinants.
Chanda PK; Natuk RJ; Mason BB; Bhat BM; Greenberg L; Dheer SK; Molnar-Kimber KL; Mizutani S; Lubeck MD; Davis AR
Virology; 1990 Apr; 175(2):535-47. PubMed ID: 2183470
[TBL] [Abstract][Full Text] [Related]
14. Simian immunodeficiency virus (SIVmac) exhibits complex splicing for tat, rev, and env mRNA.
Unger RE; Stout MW; Luciw PA
Virology; 1991 May; 182(1):177-85. PubMed ID: 2024463
[TBL] [Abstract][Full Text] [Related]
15. Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1.
Staffa A; Cochrane A
Mol Cell Biol; 1995 Aug; 15(8):4597-605. PubMed ID: 7623851
[TBL] [Abstract][Full Text] [Related]
16. Repair of a Rev-minus human immunodeficiency virus type 1 mutant by activation of a cryptic splice site.
Verhoef K; Bilodeau PS; van Wamel JL; Kjems J; Stoltzfus CM; Berkhout B
J Virol; 2001 Apr; 75(7):3495-500. PubMed ID: 11238879
[TBL] [Abstract][Full Text] [Related]
17. Identification of protein partners of the human immunodeficiency virus 1 tat/rev exon 3 leads to the discovery of a new HIV-1 splicing regulator, protein hnRNP K.
Marchand V; Santerre M; Aigueperse C; Fouillen L; Saliou JM; Van Dorsselaer A; Sanglier-Cianférani S; Branlant C; Motorin Y
RNA Biol; 2011; 8(2):325-42. PubMed ID: 21368586
[TBL] [Abstract][Full Text] [Related]
18. A naturally arising mutation of a potential silencer of exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production.
Wentz MP; Moore BE; Cloyd MW; Berget SM; Donehower LA
J Virol; 1997 Nov; 71(11):8542-51. PubMed ID: 9343212
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of intronic and exonic locations of the human immunodeficiency virus type 1 Rev-responsive element.
Campbell LH; Borg KT; Arrigo SJ
Virology; 1996 May; 219(2):423-31. PubMed ID: 8638408
[TBL] [Abstract][Full Text] [Related]
20. Control of HIV-1 env RNA splicing and transport: investigating the role of hnRNP A1 in exon splicing silencer (ESS3a) function.
Asai K; Platt C; Cochrane A
Virology; 2003 Sep; 314(1):229-42. PubMed ID: 14517076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
